Pulse Biosciences Stock Market Value
| PLSE Stock | USD 13.73 0.03 0.22% |
| Symbol | Pulse |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulse Biosciences. If investors know Pulse will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulse Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pulse Biosciences is measured differently than its book value, which is the value of Pulse that is recorded on the company's balance sheet. Investors also form their own opinion of Pulse Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pulse Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulse Biosciences' market value can be influenced by many factors that don't directly affect Pulse Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulse Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulse Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulse Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pulse Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pulse Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pulse Biosciences.
| 12/02/2025 |
| 01/01/2026 |
If you would invest 0.00 in Pulse Biosciences on December 2, 2025 and sell it all today you would earn a total of 0.00 from holding Pulse Biosciences or generate 0.0% return on investment in Pulse Biosciences over 30 days. Pulse Biosciences is related to or competes with STAAR Surgical, LifeMD, Beta Bionics,, Kestra Medical, Immatics, Opko Health, and Dianthus Therapeutics. Pulse Biosciences, Inc. operates as a novel bioelectric medicine company More
Pulse Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pulse Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pulse Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 10.73 | |||
| Value At Risk | (4.51) | |||
| Potential Upside | 3.73 |
Pulse Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pulse Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pulse Biosciences' standard deviation. In reality, there are many statistical measures that can use Pulse Biosciences historical prices to predict the future Pulse Biosciences' volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.61) | |||
| Total Risk Alpha | (0.71) | |||
| Treynor Ratio | (0.28) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pulse Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pulse Biosciences Backtested Returns
Pulse Biosciences maintains Sharpe Ratio (i.e., Efficiency) of -0.19, which implies the firm had a -0.19 % return per unit of risk over the last 3 months. Pulse Biosciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pulse Biosciences' Variance of 7.35, risk adjusted performance of (0.13), and Coefficient Of Variation of (531.24) to confirm the risk estimate we provide. The company holds a Beta of 1.83, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pulse Biosciences will likely underperform. At this point, Pulse Biosciences has a negative expected return of -0.5%. Please make sure to check Pulse Biosciences' potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Pulse Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.68 |
Very good reverse predictability
Pulse Biosciences has very good reverse predictability. Overlapping area represents the amount of predictability between Pulse Biosciences time series from 2nd of December 2025 to 17th of December 2025 and 17th of December 2025 to 1st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pulse Biosciences price movement. The serial correlation of -0.68 indicates that around 68.0% of current Pulse Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.68 | |
| Spearman Rank Test | -0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.28 |
Pulse Biosciences lagged returns against current returns
Autocorrelation, which is Pulse Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pulse Biosciences' stock expected returns. We can calculate the autocorrelation of Pulse Biosciences returns to help us make a trade decision. For example, suppose you find that Pulse Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pulse Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pulse Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pulse Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pulse Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Pulse Biosciences Lagged Returns
When evaluating Pulse Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pulse Biosciences stock have on its future price. Pulse Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pulse Biosciences autocorrelation shows the relationship between Pulse Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Pulse Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pulse Biosciences is a strong investment it is important to analyze Pulse Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulse Biosciences' future performance. For an informed investment choice regarding Pulse Stock, refer to the following important reports:Check out Pulse Biosciences Correlation, Pulse Biosciences Volatility and Pulse Biosciences Alpha and Beta module to complement your research on Pulse Biosciences. For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Pulse Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.